Analysis on the Effect of Key Intervention on Key Monitoring Drugs in People's Hospital of the Tibet Autonomous Region
Objective:To evaluate the effect of key intervention on key monitoring drugs in the People's Hospital of the Tibet Autonomous Region,so as to provide references for optimizing intervention strategy of key monitoring drugs and promoting rational clinical drug use.Methods:The Regulations on the Management of Key Monitoring Drugs in People's Hospital of the Tibet Autonomous Region of were formulated and the Lists of Key Monitoring Drugs in People's Hospital of the Tibet Autonomous Region were established in 2020.At the same time,targeted intervention measures such as special reviews on key monitoring drug prescriptions and medical orders,publicity of review results and performance appraisal linkage were carried out.The effect of key interventions on the management and clinical use of these drugs was evaluated by comparing the changes of clinical use data of key monitoring drugs in People's Hospital of the Tibet Autonomous Region from April 2019 to March 2020(before intervention),April 2020 to March 2021(the first year after intervention)and April 2021 to March 2022(the second year after intervention).Results:The sales amount of key monitoring drugs in the first year and the second year after the intervention was 14.2701 million yuan and 13.8812 million yuan,respectively,which was lower than 20.0429 million yuan before the intervention,After the intervention,the proportion of the consumption sum of key monitoring drugs in the total consumption sum of drugs was 8.33％and 7.47％,respectively,which was lower than the 10.11％before the intervention.The DDC of all key monitoring drugs were higher,and the economic burden of patients was heavier.Conclusion:The intervention of key monitoring drugs in People's Hospital of the Tibet Autonomous Region has achieved certain results,but it is still necessary to take long-term and continuous effective measures to improve the rational use of key monitoring drugs and further reduce the economic burden of patients.
key monitoring drugsquality control systemrational drug useinterventionanalysis of effect
NETL
NSTL
万方数据
